By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytRx Corporation 

11726 San Vicente Boulevard
Suite 650
Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


Company News
Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends CytRx (CYTR) Stockholders Vote "For" The Proposed Reverse Stock Split 9/21/2017 9:45:26 AM
CytRx (CYTR) Announces Amendment To Definitive Proxy Statement For Upcoming Special Meeting 9/13/2017 10:01:13 AM
CytRx (CYTR) Files Definitive Proxy Statement For Upcoming Special Meeting 8/30/2017 7:56:20 AM
CytRx (CYTR) Announces Receipt Of NASDAQ Listing Determination 8/25/2017 6:13:23 AM
CytRx (CYTR) Files Preliminary Proxy Statement For Upcoming Special Meeting 8/21/2017 7:56:54 AM
CytRx (CYTR) Reports Second Quarter 2017 Financial Results 8/3/2017 12:46:54 PM
CytRx (CYTR) Forges $356 Million Cancer Deal With Patrick Soon-Shiong's NantCell 7/28/2017 7:22:33 AM
CytRx (CYTR) Announces Reshaping Of Clinical And Regulatory Executive Team 6/13/2017 7:36:09 AM
CytRx (CYTR) Announces Update On The Regulatory Pathway For Aldoxorubicin In Soft Tissue Sarcomas 6/8/2017 9:43:59 AM
CytRx (CYTR) To Present Global Phase III Aldoxorubicin Clinical Data In Patients With Soft Tissue Sarcomas At The 2017 ASCO Annual Meeting 5/18/2017 2:05:33 PM